Novartis Ag (NVS) Sale and Maturity of Investments (2013 - 2026)
Novartis Ag (NVS) reported Sale and Maturity of Investments - Total of $88 million for Q3 2026, down 37.1% from $140 million a year earlier and down 35.3% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Sale and Maturity of Investments (2013 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Novartis Ag's Sale and Maturity of Investments - Total came in at $285 million, up 20.8% year-over-year; for FY2025, it came in at $2.18 billion, down 41.2% from FY2024.
- Sale and Maturity of Investments - Total has declined for three consecutive years, though with a five-year compound annual growth rate of 12.4% (FY2020 to FY2025).
- By year, Sale and Maturity of Investments - Total came in at $3.7 billion in FY2024 (-68.1%), $11.6 billion in FY2023 (-70.6%), $39.49 billion in FY2022 and $2.74 billion in FY2021 (+125.3%).
- Five-year quarterly Sale and Maturity of Investments - Total spans a low of $12 million in Q4 2022 and a high of $2.15 billion in Q2 2022.
- Year over year, Sale and Maturity of Investments - Total gained in three of the last eight quarters, with an average decline of 10.3%.
- The high point for year-over-year Sale and Maturity of Investments - Total in five years was Q2 2022 (growth of 772.8%); the low point was Q2 2023 (a decline of 97.7%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $136 million (Q2 2026), $37 million (Q1 2026) and $24 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 88.00 Mn |
| Jun 30, 2026 | 136.00 Mn |
| Mar 31, 2026 | 37.00 Mn |
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 140.00 Mn |
| Jun 30, 2025 | 50.00 Mn |
| Mar 31, 2025 | 25.00 Mn |
| Dec 31, 2024 | 21.00 Mn |
| Sep 30, 2024 | 226.00 Mn |
| Jun 30, 2024 | 1.08 Bn |
| Mar 31, 2024 | 63.00 Mn |
| Dec 31, 2023 | 147.00 Mn |
| Sep 30, 2023 | 91.00 Mn |
| Jun 30, 2023 | 50.00 Mn |
| Mar 31, 2023 | 63.00 Mn |
| Dec 31, 2022 | 12.00 Mn |
| Sep 30, 2022 | 26.00 Mn |
| Jun 30, 2022 | 2.15 Bn |
| Mar 31, 2022 | 66.00 Mn |
| Dec 31, 2021 | 34.00 Mn |
API Access
Novartis Ag Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();